Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 Patients.

Clin Appl Thromb Hemost · 2025 · PMC11705351 · PMID 39763448

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

20 , 21 Sulodexide's antithrombotic, profibrinolytic, and anti-inflammatory effects may be significant against the thromboinflamatory state seen in COVID-19 patients.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.